Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Baishen Changnuo Pharmaceutical is a specialized pharmaceutical manufacturer based in Yichun, Jiangxi Province, China. As a core subsidiary of the Jiangxi Baishen Pharmaceutical Group, the company focuses on the production of chemical drugs and traditional Chinese medicine (TCM) formulations. Its manufacturing capabilities include a wide range of dosage forms such as tablets, capsules, and granules, all produced under strict national GMP standards. The company's product portfolio addresses significant therapeutic areas including respiratory diseases, cardiovascular health, and gastrointestinal disorders. Jiangxi Baishen Changnuo plays a vital role in the parent group's integrated supply chain, contributing to its reputation as a prominent player in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Baishen Changnuo Pharmaceutical.